Patent-settlement expenditure treated as commercially expedient revenue outlay, with foreign-law restrictions inapplicable before the prospective amen...
International transaction benchmarking restricts transfer pricing adjustments to associated-enterprise dealings, while functional comparability govern...
Export documentation for drugs and pharmaceuticals differs by exporter status and product category. Manufacturer exporters of approved drugs must upload prescribed documents through e-Sanchit, while non-manufacturer exporters must obtain an ADC/CDSCO NOC after regulatory document verification; Customs will ordinarily rely on that verification without requesting duplicate documents. For unapproved, new or banned drugs manufactured solely for export, a CDSCO Zonal Office NOC through the SUGAM Portal must precede the State Licensing Authority's manufacturing licence, and Shipping Bill particulars must match the NOC. A temporary post-facto NOC relaxation applies until 30.09.2026 where specified State licensing and regulatory approvals exist.
Export documentation for drugs and pharmaceuticals differs by exporter status and product category. Manufacturer exporters of approved drugs must upload prescribed documents through e-Sanchit, while non-manufacturer exporters must obtain an ADC/CDSCO NOC after regulatory document verification; Customs will ordinarily rely on that verification without requesting duplicate documents. For unapproved, new or banned drugs manufactured solely for export, a CDSCO Zonal Office NOC through the SUGAM Portal must precede the State Licensing Authority's manufacturing licence, and Shipping Bill particulars must match the NOC. A temporary post-facto NOC relaxation applies until 30.09.2026 where specified State licensing and regulatory approvals exist.
Note: It is a system-generated summary and is for quick reference only.
TaxTMI 
Join Channel
TaxTMI 
